Marc Nathaniel Baskin, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fever | 6 | 2013 | 1605 | 0.460 |
Why?
|
| Bacteremia | 3 | 2013 | 983 | 0.290 |
Why?
|
| Hospitals, Pediatric | 5 | 2022 | 1856 | 0.260 |
Why?
|
| Rhabdomyolysis | 1 | 2006 | 150 | 0.250 |
Why?
|
| Anemia, Sickle Cell | 1 | 2013 | 1065 | 0.230 |
Why?
|
| Bacterial Infections | 5 | 2000 | 1390 | 0.200 |
Why?
|
| Bronchiolitis | 3 | 2013 | 492 | 0.200 |
Why?
|
| Urinary Tract Infections | 6 | 2011 | 804 | 0.200 |
Why?
|
| Catheterization, Central Venous | 2 | 2000 | 537 | 0.180 |
Why?
|
| Emergency Service, Hospital | 7 | 2022 | 7871 | 0.170 |
Why?
|
| Craniocerebral Trauma | 1 | 2003 | 493 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 3 | 2013 | 7469 | 0.150 |
Why?
|
| Fever of Unknown Origin | 2 | 1993 | 94 | 0.130 |
Why?
|
| Hospital Units | 1 | 1997 | 141 | 0.130 |
Why?
|
| Acute Kidney Injury | 1 | 2006 | 1946 | 0.110 |
Why?
|
| Diagnostic Errors | 2 | 2018 | 1278 | 0.110 |
Why?
|
| Brain Diseases | 1 | 2003 | 1551 | 0.110 |
Why?
|
| Infant | 18 | 2013 | 36485 | 0.110 |
Why?
|
| Ambulatory Care | 3 | 2013 | 2780 | 0.100 |
Why?
|
| Asthma | 3 | 2022 | 6268 | 0.100 |
Why?
|
| Respiratory Sounds | 2 | 2007 | 702 | 0.100 |
Why?
|
| Ceftriaxone | 2 | 1992 | 175 | 0.100 |
Why?
|
| Hospital Costs | 2 | 2013 | 956 | 0.090 |
Why?
|
| Boston | 5 | 2013 | 9360 | 0.090 |
Why?
|
| Leukocytosis | 1 | 2011 | 248 | 0.090 |
Why?
|
| Length of Stay | 3 | 2022 | 6489 | 0.080 |
Why?
|
| Seizures | 1 | 2003 | 2996 | 0.080 |
Why?
|
| Bicarbonates | 2 | 1991 | 293 | 0.080 |
Why?
|
| Child, Preschool | 9 | 2022 | 42606 | 0.080 |
Why?
|
| Meningitis, Bacterial | 1 | 2010 | 222 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 2174 | 0.070 |
Why?
|
| Pediatrics | 2 | 2000 | 3621 | 0.070 |
Why?
|
| Jugular Veins | 1 | 1989 | 211 | 0.070 |
Why?
|
| Health Resources | 1 | 2013 | 948 | 0.070 |
Why?
|
| Patient Discharge | 2 | 2018 | 3467 | 0.070 |
Why?
|
| Patient Care Team | 2 | 1997 | 2516 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 2006 | 0.070 |
Why?
|
| Retrospective Studies | 11 | 2022 | 81659 | 0.060 |
Why?
|
| Patient Readmission | 2 | 1997 | 3283 | 0.060 |
Why?
|
| Child | 10 | 2022 | 80771 | 0.060 |
Why?
|
| Pyelonephritis | 2 | 2003 | 76 | 0.060 |
Why?
|
| Catheterization, Peripheral | 1 | 1989 | 346 | 0.060 |
Why?
|
| Oxygen | 1 | 1997 | 4252 | 0.060 |
Why?
|
| Outpatients | 1 | 2013 | 1600 | 0.060 |
Why?
|
| Risk | 2 | 2016 | 9606 | 0.060 |
Why?
|
| Foot | 1 | 1989 | 576 | 0.060 |
Why?
|
| Sodium | 1 | 1989 | 1594 | 0.050 |
Why?
|
| Acute Disease | 3 | 2006 | 7236 | 0.050 |
Why?
|
| Pulmonary Embolism | 1 | 2016 | 2598 | 0.050 |
Why?
|
| Urography | 1 | 2003 | 316 | 0.050 |
Why?
|
| Resuscitation | 2 | 2000 | 681 | 0.050 |
Why?
|
| Foreign Bodies | 1 | 2005 | 403 | 0.050 |
Why?
|
| Infant, Newborn | 7 | 2011 | 26396 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2018 | 4881 | 0.040 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 2 | 1997 | 55 | 0.040 |
Why?
|
| Femoral Vein | 1 | 2000 | 156 | 0.040 |
Why?
|
| Cefotaxime | 1 | 1999 | 36 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2007 | 1963 | 0.040 |
Why?
|
| Esophagus | 1 | 2005 | 1041 | 0.040 |
Why?
|
| Urine | 1 | 2000 | 362 | 0.040 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2003 | 433 | 0.040 |
Why?
|
| Cephalosporins | 1 | 1999 | 200 | 0.040 |
Why?
|
| Blood | 1 | 2000 | 596 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2007 | 2163 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2000 | 540 | 0.040 |
Why?
|
| Adolescent | 6 | 2022 | 89046 | 0.040 |
Why?
|
| Hospitalization | 5 | 2022 | 10815 | 0.030 |
Why?
|
| Hospital Departments | 1 | 1997 | 134 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 7435 | 0.030 |
Why?
|
| Humans | 24 | 2022 | 767040 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 1997 | 386 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2016 | 41718 | 0.030 |
Why?
|
| Triage | 1 | 2022 | 995 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1997 | 345 | 0.030 |
Why?
|
| Male | 14 | 2016 | 364203 | 0.030 |
Why?
|
| Female | 13 | 2016 | 396660 | 0.030 |
Why?
|
| Polymyxin B | 1 | 1991 | 44 | 0.020 |
Why?
|
| Neisseria meningitidis | 1 | 1991 | 111 | 0.020 |
Why?
|
| Inappropriate Prescribing | 1 | 2013 | 212 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 1992 | 551 | 0.020 |
Why?
|
| Unnecessary Procedures | 1 | 2013 | 412 | 0.020 |
Why?
|
| Bacteria | 2 | 2010 | 2212 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 12986 | 0.020 |
Why?
|
| Gastroenteritis | 1 | 1992 | 233 | 0.020 |
Why?
|
| Administration, Oral | 3 | 2007 | 4026 | 0.020 |
Why?
|
| Spinal Puncture | 1 | 2011 | 284 | 0.020 |
Why?
|
| Endotoxins | 1 | 1991 | 519 | 0.020 |
Why?
|
| Sodium Bicarbonate | 1 | 1989 | 60 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 1994 | 744 | 0.020 |
Why?
|
| Comorbidity | 1 | 2003 | 10582 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 1992 | 518 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 1989 | 383 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 1994 | 1320 | 0.020 |
Why?
|
| Critical Illness | 1 | 2000 | 2753 | 0.020 |
Why?
|
| Kidney | 1 | 2003 | 7063 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1997 | 1804 | 0.020 |
Why?
|
| Patient Admission | 1 | 1994 | 1364 | 0.020 |
Why?
|
| Urinalysis | 2 | 2003 | 369 | 0.020 |
Why?
|
| Numismatics | 1 | 2005 | 16 | 0.020 |
Why?
|
| Body Temperature | 1 | 1989 | 780 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2850 | 0.020 |
Why?
|
| Prevalence | 2 | 2011 | 15851 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3431 | 0.020 |
Why?
|
| Feces | 1 | 1992 | 1508 | 0.020 |
Why?
|
| Remission, Spontaneous | 1 | 2005 | 384 | 0.010 |
Why?
|
| Shock, Septic | 1 | 1991 | 772 | 0.010 |
Why?
|
| Veins | 1 | 1989 | 769 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2013 | 6331 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2003 | 24299 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 2 | 1999 | 5537 | 0.010 |
Why?
|
| Dogs | 1 | 1989 | 3834 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 15925 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 20169 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1991 | 2217 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 14672 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 2005 | 398 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2013 | 2232 | 0.010 |
Why?
|
| ROC Curve | 1 | 2011 | 3618 | 0.010 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 1 | 2003 | 81 | 0.010 |
Why?
|
| Models, Statistical | 2 | 2013 | 5098 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1989 | 1794 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2007 | 2658 | 0.010 |
Why?
|
| Respiration | 1 | 2007 | 1655 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1997 | 15424 | 0.010 |
Why?
|
| Ureter | 1 | 2003 | 364 | 0.010 |
Why?
|
| Cefixime | 1 | 1999 | 13 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 20741 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1997 | 22254 | 0.010 |
Why?
|
| Heart Arrest | 1 | 1989 | 1516 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2007 | 12451 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 1987 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2013 | 3854 | 0.010 |
Why?
|
| Adult | 3 | 2003 | 223317 | 0.010 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2003 | 640 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 1997 | 65295 | 0.010 |
Why?
|
| Blood Pressure | 2 | 1991 | 8531 | 0.010 |
Why?
|
| Theophylline | 1 | 1997 | 133 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2003 | 1155 | 0.010 |
Why?
|
| Internship and Residency | 1 | 1997 | 5947 | 0.010 |
Why?
|
| Age Factors | 1 | 1993 | 18401 | 0.010 |
Why?
|
| Albuterol | 1 | 1997 | 211 | 0.010 |
Why?
|
| Algorithms | 1 | 2016 | 14098 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 36582 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1997 | 1377 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1999 | 2227 | 0.010 |
Why?
|
| Vital Capacity | 1 | 1997 | 996 | 0.010 |
Why?
|
| United States | 1 | 2022 | 72971 | 0.010 |
Why?
|
| Risk Factors | 2 | 2011 | 74886 | 0.010 |
Why?
|
| Bronchodilator Agents | 1 | 1997 | 513 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 1997 | 1830 | 0.010 |
Why?
|
| Decision Trees | 1 | 1992 | 508 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1992 | 39317 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 29963 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 59980 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2003 | 6000 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 1997 | 2741 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1999 | 2697 | 0.000 |
Why?
|
| Leukocyte Count | 1 | 1992 | 1606 | 0.000 |
Why?
|
| Recurrence | 1 | 1999 | 8504 | 0.000 |
Why?
|
| Rabbits | 1 | 1991 | 4751 | 0.000 |
Why?
|
| Logistic Models | 1 | 1999 | 13284 | 0.000 |
Why?
|
| Attitude of Health Personnel | 1 | 1997 | 3928 | 0.000 |
Why?
|
| Animals | 2 | 1991 | 168965 | 0.000 |
Why?
|
| Heart Rate | 1 | 1991 | 4209 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1991 | 4209 | 0.000 |
Why?
|
| Time Factors | 1 | 2000 | 40154 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2003 | 54886 | 0.000 |
Why?
|